Skip to content

ORBIMED ADVISORS LLC: ORIC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ORIC, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,555,900 ORIC shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 1,555,900 shares
    Change vs previous 13F -459,100 shares

    0.38% of the 13F portfolio, value $20,957,973.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  2. period ended2026-06-30
    13F 2,015,000 shares
    Change vs previous 13F -678,929 shares

    0.41% of the 13F portfolio, value $21,822,450.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 2,693,929 shares
    Change vs previous 13F -947,827 shares

    0.74% of the 13F portfolio, value $34,132,080.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 3,641,756 shares
    Change vs previous 13F 0 shares

    0.61% of the 13F portfolio, value $29,789,564.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 3,641,756 shares
    Change vs previous 13F +2,742,475 shares

    1.05% of the 13F portfolio, value $43,701,072.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 899,281 shares
    Change vs previous 13F +199,281 shares

    0.23% of the 13F portfolio, value $9,127,702.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 700,000 shares
    Change vs previous 13F not available

    0.09% of the 13F portfolio, value $3,906,000.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).